Elicio Therapeutics Inc. (ELTX)
NASDAQ · Healthcare
Elicio Therapeutics Inc. EPS 2020–2022
Elicio Therapeutics Inc. annual/quarterly eps history and growth rate from 2020 to 2023. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Elicio Therapeutics Inc. eps for the quarter ending March 31, 2023 was $24.77, a 5060.42% increase year-over-year.
- Elicio Therapeutics Inc. annual eps for 2022 was $89.27, a 4525.39% increase from 2021.
- Elicio Therapeutics Inc. annual eps for 2021 was $1.93, a 64.46% decrease from 2020.
- Elicio Therapeutics Inc. annual eps for 2020 was $5.43.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Elicio Therapeutics Inc. EPS — FAQ
Elicio Therapeutics Inc. (ELTX) eps over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Elicio Therapeutics Inc.'s eps?
Elicio Therapeutics Inc. (ELTX) reported eps of $-89.27 for fiscal 2022.
Where can I see ELTX's eps history?
The chart and table above show Elicio Therapeutics Inc.'s eps by year and by quarter, including the growth rate.